Systematic review of 60 studies (13 meta-analysed, 40,287 participants): sentinel node biopsy for cutaneous melanoma was associated with lower risk of death from melanoma (adjusted HR 0.86) and recurrence (HR 0.71) vs no biopsy.
Meta-analysisn = 40,287
Varey et al. Assessment of survival benefit from sentinel node biopsy for melanoma: a systematic review and meta-analysis